ArticleHuman reproduction (Oxford, England)2024

BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.

Rita Lobo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.